Crispr Therapeutics shares owned by InTrack Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by InTrack Investment Management
from 13F filings
Historical chart of InTrack Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by InTrack Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by InTrack Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $522k | 7.7k | 68.16 |
More positions owned by InTrack Investment Management
View all positions for InTrack Investment Management